Clinical Trial Update: Metabolic Changes in Prostate Cancer Patients With Androgen-ablation Therapy (AAT)

View source ↗

Summary

Clinical trial update describing metabolic changes observed in prostate cancer patients receiving androgen-ablation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Prostatic Cancer | Status: COMPLETED